Comparison of RTS and MGAP Scores in Predicting Outcomes of Trauma Patients (NCT06744985) | Clinical Trial Compass
RecruitingNot Applicable
Comparison of RTS and MGAP Scores in Predicting Outcomes of Trauma Patients
Iraq200 participantsStarted 2025-01-20
Plain-language summary
The goal of this prospective cohort study is to compare the predictive accuracy of the Revised Trauma Score (RTS) and the MGAP score in determining clinical outcomes among multiple trauma patients hospitalized at a trauma center in Iraq.
The main questions it aims to answer are:
Which score, RTS or MGAP, provides a more accurate prediction of clinical outcomes, including mortality? Are there specific subgroups of trauma patients where one scoring system outperforms the other?
Participants will:
Be assessed using both the RTS and MGAP scores upon admission. Have their clinical outcomes, including mortality and other relevant indicators, monitored throughout their hospital stay.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Presentation to the trauma center within 6 hours of injury.
* Availability of complete clinical and demographic data for scoring using RTS and MGAP.
* Patients who consent to participate in the study or whose legal representatives provide consent.
* Capability to assess outcomes such as survival, ICU admission, and complications.
Exclusion Criteria:
* Patients who expired before scoring or evaluation
* Missing or unreliable medical data for RTS or MGAP score calculations.
* Transfers from other facilities with interventions that could impact RTS or MGAP reliability.
* Pregnant patients, due to the unique considerations of trauma in pregnancy.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
In hospital mortality
Timeframe: In-Hospital Phase (average of 7 days through discharge)
2
Accuracy Assessment of the Revised Trauma Score (RTS)